Cargando…
Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691856/ https://www.ncbi.nlm.nih.gov/pubmed/34957418 http://dx.doi.org/10.1016/S2665-9913(21)00393-3 |
| _version_ | 1784618834743787520 |
|---|---|
| author | Smetanova, Jitka Strizova, Zuzana Sediva, Anna Milota, Tomas Horvath, Rudolf |
| author_facet | Smetanova, Jitka Strizova, Zuzana Sediva, Anna Milota, Tomas Horvath, Rudolf |
| author_sort | Smetanova, Jitka |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8691856 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86918562021-12-22 Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab Smetanova, Jitka Strizova, Zuzana Sediva, Anna Milota, Tomas Horvath, Rudolf Lancet Rheumatol Comment Elsevier Ltd. 2022-03 2021-12-21 /pmc/articles/PMC8691856/ /pubmed/34957418 http://dx.doi.org/10.1016/S2665-9913(21)00393-3 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Smetanova, Jitka Strizova, Zuzana Sediva, Anna Milota, Tomas Horvath, Rudolf Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab |
| title | Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab |
| title_full | Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab |
| title_fullStr | Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab |
| title_full_unstemmed | Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab |
| title_short | Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab |
| title_sort | humoral and cellular immune responses to mrna covid-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691856/ https://www.ncbi.nlm.nih.gov/pubmed/34957418 http://dx.doi.org/10.1016/S2665-9913(21)00393-3 |
| work_keys_str_mv | AT smetanovajitka humoralandcellularimmuneresponsestomrnacovid19vaccinesinpatientswithaxialspondyloarthritistreatedwithadalimumaborsecukinumab AT strizovazuzana humoralandcellularimmuneresponsestomrnacovid19vaccinesinpatientswithaxialspondyloarthritistreatedwithadalimumaborsecukinumab AT sedivaanna humoralandcellularimmuneresponsestomrnacovid19vaccinesinpatientswithaxialspondyloarthritistreatedwithadalimumaborsecukinumab AT milotatomas humoralandcellularimmuneresponsestomrnacovid19vaccinesinpatientswithaxialspondyloarthritistreatedwithadalimumaborsecukinumab AT horvathrudolf humoralandcellularimmuneresponsestomrnacovid19vaccinesinpatientswithaxialspondyloarthritistreatedwithadalimumaborsecukinumab |